Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_provenance.
- NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_assertion description "[Moreover, a set of 6 genes comprising ATR, LYK5, MPP2, PIK3CG, PIK4CA, and WNK4 were identified as contributing to both cell proliferation and resistance to cisplatin treatment in medulloblastoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_provenance.
- NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_assertion evidence source_evidence_curated NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_provenance.
- NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_assertion SIO_000772 21652733 NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_provenance.
- NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_assertion wasDerivedFrom ctd_human-20130708 NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_provenance.
- NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_assertion wasGeneratedBy ECO_0000218 NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP31118.RAtGqv-obTnZKbk1u5nKTeXYspt58L2GM-nOqqlI5z_2Y130_provenance.